These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1637 related articles for article (PubMed ID: 18667798)

  • 41. Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep.
    Lorton D; Lubahn CL; Estus C; Millar BA; Carter JL; Wood CA; Bellinger DL
    Neuroimmunomodulation; 2006; 13(5-6):357-74. PubMed ID: 17709958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.
    Szodoray P; Jonsson R
    Scand J Immunol; 2005 Nov; 62(5):421-8. PubMed ID: 16305638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of the brain-gut axis in the pathophysiology of Crohn's disease.
    Stasi C; Orlandelli E
    Dig Dis; 2008; 26(2):156-66. PubMed ID: 18431066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?
    Lam-Tse WK; Lernmark A; Drexhage HA
    Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
    Smedby KE; Baecklund E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammation and cortisol response in coronary artery disease.
    Nijm J; Jonasson L
    Ann Med; 2009; 41(3):224-33. PubMed ID: 18979272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphoproliferative disorders in Sjögren's syndrome.
    Masaki Y; Sugai S
    Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocrine alterations in primary Sjogren's syndrome: an overview.
    Mavragani CP; Fragoulis GE; Moutsopoulos HM
    J Autoimmun; 2012 Dec; 39(4):354-8. PubMed ID: 22695186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuro-endocrine-immune axis in human rheumatoid arthritis.
    Sakane T; Suzuki N
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):417-27. PubMed ID: 11140469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease.
    O'Kane M; Murphy EP; Kirby B
    Exp Dermatol; 2006 Mar; 15(3):143-53. PubMed ID: 16480421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The concept of stress and the role of hypothalamic and extra-hypothalamic corticotropin-releasing factor (CRF) in the integration of the neuroendocrine and immune responses. Clinical and experimental aspects].
    Puri PL; Palma A; Fabbri A
    Minerva Endocrinol; 1994 Mar; 19(1):19-28. PubMed ID: 8035767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of human intracisternal A-type retroviral particles in autoimmunity.
    Sander DM; Szabo S; Gallaher WR; Deas JE; Thompson JJ; Cao Y; Luo-Zhang H; Liu LG; Colmegna I; Koehler J; Espinoza LR; Alexander SS; Hart DJ; Tom DM; Fermin CD; Jaspan JJ; Kulakosky PC; Tenenbaum SA; Wilson RB; Garry RF
    Microsc Res Tech; 2005 Nov; 68(3-4):222-34. PubMed ID: 16276517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?
    Staines DR
    Med Hypotheses; 2004; 62(5):646-52. PubMed ID: 15082083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimalarials in Sjögren's syndrome--the Greek experience.
    Manoussakis MN; Moutsopoulos HM
    Lupus; 1996 Jun; 5 Suppl 1():S28-30. PubMed ID: 8803907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
    Fox RI; Konttinen Y; Fisher A
    Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
    Nordmark G; Alm GV; Rönnblom L
    Nat Clin Pract Rheumatol; 2006 May; 2(5):262-9. PubMed ID: 16932699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Personality, manual preference and neuroendocrine reactivity in hirsute subjects.
    Martin Martins J; Do Vale S; Trinca A; Saldanha C; Martins E Silva J
    Physiol Behav; 2004 Sep; 82(4):741-9. PubMed ID: 15327925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autonomic dysfunction in autoimmune rheumatic disease.
    Stojanovich L
    Autoimmun Rev; 2009 Jun; 8(7):569-72. PubMed ID: 19393212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of the thymus-hypothalamus-pituitary-gonadal axis in normal immune processes and autoimmunity.
    Golsteyn EJ; Fritzler MJ
    J Rheumatol; 1987 Oct; 14(5):982-90. PubMed ID: 3323509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 82.